News
Johnson & Johnson today announced first results from Cohort 4 of the Phase 2b SunRISe-1 study evaluating TAR-200?an intravesical gemcitabine releasing system?for patients with certain types of bladder ...
As The Last of Us Season 2 continues to air, let's take a look at Naughty Dog's next potential Hollywood adaptation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback